Callouts & quotes from 10,384+ activist slides

"The Audit Committee concluded that Dan Bodner, Verint's Chief Executive Officer, or any other current executive officer of the Company, did not participate in unlawful activities or wrongful conduct. Nevertheless, the Audit Committee did note that the product revenue management practices described above, while not unlawful or violative of accounting principles, were not best business practice and should be remedied. — VRNT 03/20/08 8-K"

"We have received investor feedback advising it would be best for us to eliminate the related party obligations, expenses, balances, and reporting associated with Cuattro since 2013. The Transactions address these concerns and are in the best interest of our stockholders. We believe the Transactions will eliminate distractions and allow us to more strongly focus on our collective success in 2019 and beyond. — Scott Humphrey, Heska Chair"

"“Diazoxide I use regularly, and I use it in babies... is it worth the difference? Obviously, when we participated in the trial, we weren't aware of the costs and so on... it's probably just the diazoxide, where the extended release probably makes no difference at all... half to $1 million is a bit excessive for something that you could do for a year, for $1,000 at most.” — Trial investigator, endocrinologist, key opinion leader for PWS"

"“The most important thing in this business is not doing your own work. The most important thing is to develop your market and get the hourly pay. All of your members are your market. The bigger your market, the bigger your hourly pay will be. They will all be connected to you.” — Ms. Ping, Guangzhou; “I still have profit even if I don’t do anything.” — Ms. Zhang, Guangzhou; “Even if I do nothing I still get paid.” — Ms. Chen, Guangzhou"

""The Report also quotes two advertising agents who claimed to be “core” advertising agents for QTT - the truth is, Hunan Jie Jisuan Computer Tech Company (湖南皆计算网络科技有限公司) is one of QTT’s agents with year-to-date transactions amounting to only RMB0.4 million; as for Shanghai Jusou Info Tech Co.(上海聚搜信息技术有限公司), we do not have any direct business relationships with that particular advertising agent per our internal check." — Qutoutiao, Inc."

"It is getting worse and worse!!! Everything was fine at the beginning, the rewards were interesting, there were regular quests (and different ones). The articles were a lot cheaper. I went from 300,000 (in-game) cash to 60,000 in a few weeks without changing the way I play. I sent e-mails but nobody wants to tell me why. It is a shame because when I will be out of cash, I will not be able to play anymore. — Mélissa (Google Play Review)"

""Our acquisition strategy has really been focused on rebuilding our pipeline over the last 2 years [...] our plan is still to keep rebuilding that pipeline, continue the path that we are on from a diversification standpoint, and most importantly, sort of stay disciplined on matching the risk that we take with a particular BD or partnership or license or acquisition with the value that we pay for it" — Aradhana Sarin, CFO, March 3, 2020"

"[We] plan to submit for Shonin approval in Japan later this year...We have also accelerated our efforts into Japan where we are moving forward with an application for regulatory approval. Japan is the second largest ambulatory cardiac monitoring market in the world, where reimbursement has historically been very good and physicians have been expressing strong interest in our technology. — iRhythm CEO Blackford on Q4 2021 Earnings Call"

"Almost no career opportunities, non-existent training, terrible technology infrastructure, and overly bureaucratic. The fact that there is actually a committee to oversee other committees that set internal policies kind of says it all. Unimaginative senior management that is always reacting to competition. Bloated middle management while underinvesting in products, services, and line employees that actually drive revenues. — Glassdoor"

"I just wanted to talk a little bit about implementation of End-to-End. I think in North America, we're kind of at a 2-year point for that being put in place, and I understand it was the lead market. There was going to be a lot of learning and adjusting. But it looks like you're still -- share trends are still not clearly where they need to be in the U.S. — Lauren Lieberman, Barclays Analyst, on P&G's Q4'17 Earnings Call, July 27, 2017"

""We think that MHP could evaluate a potential sale/spin of the Education segment (22% of MHP profits). We view the Education properties as relatively low growth (LSD) and low margin (essentially 10-15% since 1995) — which put it at odds with much of S&P Ratings, M-H Financial, and Platts. Education has also struggled in recent years amid tough times for local/state budgets, and lagged competitor Pearson." — J.P. Morgan, August 1, 2011"

"“its not like anything that required the device but they would use it out of convenience, which is a very expensive backup plan...even when it wasn’t clinically indicated”; “we’ve since remedied that.” The “surgical director is very mindful of cost...and questioned if we’re using it too liberally, like on organs we would have taken otherwise before TransMedics was available...the cost has been a concern.” — UCSF hospital administrator"

""Today, 30 years after the birth of the company, Novamerican Steel is shedding the final vestiges of its outdated past and publicly marking the start of our very different journey." — Corrado De Gasperis, Barzel's CEO, Feb 13, 2009. "On September 15, 2009 (the "Petition Date"), the Company and its U.S. subsidiaries filed voluntary petitions for relief under Chapter 11 of the Bankruptcy Code" — Barzel Bankruptcy Filing, Sept 15, 2019."

""Peter is in Seattle. He also has a house somewhere like in; I don't know, New Hampshire or something like that. But generally, the management is virtual. Thomas Kramer, the CFO, goes in every day. But Peter not, Jungsang not, Chris not, and they are supposedly opening a Seattle office and a New York office and a Boston office because people don't want to move. Peter would show up at the office maybe once a month." — Former executive"

"Our third strategic pillar of growth is expanding our connected customer experience. On the 13-week to 13-week basis, our fourth quarter e-commerce sales increased 45.1% from last year and 61.7% when measured on a 2-year compound annual growth rate basis from fiscal 2019. As a result, our fourth quarter e-commerce sales penetration rate increased 190 basis points to 16.4% from 14.5% last year. — Floor & Decor Holdings, Inc. (Q4 2021)"

"As a result of performing the above, we identified the greatest potential for fraud in the following area, and our specific procedures performed to address it are described below: Revenue recognition (topside journals posted to revenue): Using our analytics tools we performed an analysis over the top topside journals posted to revenue near to year end and obtained the rationale and corroborative evidence for such journals. — Deloitte"

"The Commission tested the communication of advertisements containing testimonials that clearly and prominently disclosed either "Results not typical" or the stronger "These testimonials are based on the experiences of a few people and you are not likely to have similar results." Neither disclosure adequately reduced the communication that the experiences depicted are generally representative. — FTC Section 255.2 Consumer Endorsements"

"I don't think there's any way that anyone can ensure retail sales, except to look at the evidence of how many people do we have who came back to Herbalife with a garage full of product and said, you know, "I've been duped into this, and here's my product. I can't sell this product. I'm not able to sell this product"? The evidence is to the contrary. The evidence is considerably to the contrary. — Charles Patterson, Herbalife Attorney"

"In a somewhat surprising tactic, PSX management talked down the potential SOTP upside (i.e.. [stating that the Company is] fairly valued), with ~1.0x multiple market premium vs. peers reflective of some of that value capture... [PSX considers the] potential uplift would be further reduced by meaningful compression on the "remainco", with the stand-alone Refining business closer to a 5.0x EBITDA business... — Piper Sandler, March 2025"

"“...we got to the latter part of January and spent a good part of February trying to figure out what the heck was going on and what we had to do.” — Dave Cote, Executive Chairman; “In short, we screwed up... We significantly underestimated the magnitude of the material and freight inflation...” — Robert Johnson, CEO; “Some of you may be wondering why I don't get more involved. The answer is, I have...” — Dave Cote, Executive Chairman"

""I am a cardiac surgeon. Our program does about 60 heart transplants a year. We do not do lung transplants. We do Impeller liver transplants; I’m not involved in those. We use TransMedics in 10-12% of our cases a year. For disclosure, I was on the FDA panel that voted to approve TransMedics, so I’m very familiar with that product. We began to use it about two years ago." — Cardiac transplant surgeon at a major Midwest academic center"

"“The single-cell stuff is really interesting, but you can sequence single cells already. We already have single cell processes in place, and we can use cell sorting to get to those cells. That's correct. So, it is a really fancy cell screening instrument. That's a good way of putting it, actually. You can do that stuff, but you can do it much more cheaply with methods that scientists actually use.” — Bristol Meyers Squibb employee #1"

"A significant portion of UOL's revenues and profits come from dial-up Internet and DSL access services and related services and advertising revenues. UOL's dial-up and DSL Internet access pay accounts and revenues have been declining and are expected to continue to decline due to the continued maturation of the market for dial-up and DSL Internet access, competitive pressures in the industry and limited sales efforts — UOL Disclosure"

"New systems that are coming out will be lower cost, and they will also test more than one sample at a time. Accelerate has a module that can do one sample at a time and you need 7 hours to process the sample, so all other samples will wait till this is done. What do you do? You need to buy the second system to truly incorporate it into rapid AST testing. It is modular with Accelerate, but then you pay a multiple. — Avails Medical rep"

"Box is one of the most predictable models in all of software. All right. So when we think about Box at $1 billion scale, we expect that the customers that we already have today are going to contribute more than 75% of that revenue. So those best-in-class customer economics and the trends we're seeing are the biggest reason that we're so confident in our path to becoming a $1 billion company. — CFO Dylan Smith, BoxWorks, October 2017"

""Ultimately we believe that the measures that TI has announced so far look sensible and put the company on track for improving trends." — Credit Suisse, February 27, 2019; "We have met TI management on the road, feedback from investors so far on the new CEO is positive and that he comes across well." — BAML, February 27, 2019; "Telecom Italia boss Luigi Gubitosi is sending the right signals." — Lisa Jucca, Reuters, February 21, 2019"

""As part of its lawsuit, Boots Capital sought . . . to object to the appointment of our new CEO Steven Moskowitz to the Board and its resulting expansion of the Board" — Crown Castle Inc. Investor Presentation. "Boots has interfered with the Fiber review at multiple stages through unneeded & baseless litigation . . . by seeking to keep our CEO, a critical input in the review, off the Board" — Crown Castle Inc. Investor Presentation."

"Not so much because again, they're tied to Nvidia, which is this high, you know, the Lamborghini of AI chips. If they were pivoting to inference, they would want to be running the Toyota Camrys of inference chips – which is kind of what the Google TPUs and the Amazon [Inferencia] and [Azure] Maia and all that kind of stuff is. Those chips are designed to be super-efficient and get you from A to B. — Former Nvidia Principal Architect"

"“I just didn’t think it worked...they’re basing so much on subjectivity.” Regarding the negligible BMI outcomes: “yes, not that remarkable...it didn’t really change the weight...they got a statistician who did all this remarkable testing and, oh, we came up with something...so I think they played with the data until they finally got something that worked.” — Trial investigator and physician; one of the leading KOL’s in the PWS field"

"Regarding your question 2.5: The freeXmedia transaction was reviewed in great detail at that time both internally and externally. We have commissioned appraisal reports et al and sought legal advice for the acquisition of freeXmedia. Neither the external consultants nor the supervisory board or shareholders objected to the transaction. We thus have no reason to assume there was anything unlawful about the transaction. — Dr. Metzner"

"“There was no one in the battery R&D community that did not think that Sakti 3 was a fraud and was not angered by it. Everyone knew. GM invested, and I think, thanks to Khosla, found a greater fool in Dyson to dump it on. They had very, very small cells. They never really showed any performance data. It seemed to be a manufacturing process that would be expensive or impossible to scale up, and it never scaled.” – Solid-state expert"

""It's a super-hard problem. Now, let's think about that in a multi-layer concept. I stack up 50 layers of anodes and cathodes and separators, and now every other layer expands. The anodes expand, the cathodes don't, and everything moves, and I've got to connect tabs to all of those layers to get current in and out, and I've got to keep it all compressed and consolidated. Imagine that every layer moves 30 microns." — Former employee"

""Let's address customer momentum. We expanded and extended our strategic partnership with Baker Hughes last quarter for the second time. . .This October, we increased the value of the contract again, this time by an additional $45 million to $495 million and extended this term from five to six years. Importantly now guaranteeing a minimum of $357 million in revenue to C3 over the next 3.5 years." — CEO Siebel, 2Q'22 Conference Call"

"“In a somewhat surprising tactic, PSX management talked down the potential SOTP upside (i.e.. [stating that the Company is] fairly valued), with ~1.0x multiple market premium vs. peers reflective of some of that value capture… [PSX considers the] potential uplift would be further reduced by meaningful compression on the “remainco”, with the stand-alone Refining business closer to a 5.0x EBITDA business…” — Piper Sandler, March 2025"

""[At ConocoPhillips] we were always telling the Street that being an integrated company had significant value. I was an advocate late in my career that we should look seriously at splitting the company. The market was telling us that the company valuation was such that these are really two different companies. You end up with a sub-allocation of capital. I think history has shown that it was the right decision." — Sigmund Cornelius"

"Revenue base is almost entirely recurring subscriptions with attractive retention rates — Deal presentation. A portion of RCA's client agreements do not have automatic renewal clauses at the end of the subscription period. Due to the historically high retention rate and expectation that a substantial portion of the client agreements will be renewed, the associated revenue is recorded as recurring subscription revenue — SEC filings."

"And as I mentioned on the press release and on the call, we've seen it as a key driver of our ability to acquire new customer by adding the CTV element and a big screen capability into our holistic multi screen type of offering. That was -- it was more important for us to use it as acquiring new deals than to have CTV dollars by itself, which is on the neighborhood of $2 million in the quarter. — Perion Network Management (Q1 2021)"

"“My Administration would have also sold the government’s common stock in these companies at a huge profit and fully privatized the companies. The idea that the government can steal money from its citizens is socialism and is a travesty brought to you by the Obama/Biden administration. My Administration was denied the time it needed to fix the problem because of the unconstitutional restriction on firing Mel Watt.” — Donald J. Trump"

"MagnaChip recognized revenue on sales of incomplete or unshipped products...and delayed booking obsolete or aged inventory to manipulate its gross margin. The SEC detailed how Magnachip “overstated revenue for nearly two years in response to immense pressure...each quarter to meet revenue and gross margin targets that had been communicated to the public...a panoply of accounting tricks to artificially meet financial targets.” — SEC"

"“They initially got traction in lung. I think their peak year - and this is again where the company's dishonest... It plummeted for two reasons. One, you now had to pay for an organ whether you used it or not. Two, enthusiasm for XVIVO's device with Lung Bioengineering. Number three, which really put the nail on the coffin, was the 10-degree Celsius storage story.” — Prominent surgeon, director of leading academic transplant center"

"“Those items are just warnings...you're not going to run into those issues hardly ever”; “I’ve never ordered an EKG...that’s what I tell doctors, these are just warnings...technically speaking, you don’t have to do anything...you can just prescribe it, which is what we do.” — Bay Area-based speaker; “I do not run any EKG’s...I don’t check lab work...remember, most narcoleptics are...pretty damned healthy...” — Alabama-based speaker"

"“Oh, 100%, absolutely. So, I actually introduced them to [top prescriber name redacted]...there's no question. Look, they're never going to put it in writing but make no mistake, it was very clear, if there are high prescribers, then let's see if we can get them on the speakers bureau. If they're good speakers, great. But more important, that you get them on there.” — Ex-Harmony territory manager for a large region in the northeast"

"RESUELVE, ÚNICO.- Revocar en todas sus partes la Resolución de Administrativa AJAM/DJU/AL/RES/ADM/1/2015, de 2 de octubre de 2015, emitida por el Director Ejecutivo de la Autoridad Jurisdiccional Administrativa Minera – AJAM, dentro del Recurso Jerárquico presentado por la Empresa Minera Alcira S.A. representado legalmente por CAI XIMING. Registrese, comuniquese y archivese. — Cesar Navarro Miranda, MINISTRO DE MINERIA Y METALURGIA"

"First, Ms. Liu held a majority shareholder position, along with key executive management positions including legal representative, executive director and general manager, in Khorgos Huanxu Technology Co., Ltd. (“KHT”). On September 30, 2018, KHT was listed as the sole shareholder of Beijing Bairui Media Co., Ltd. (“Bairui”), a company previously controlled by YT with a subscribed capital of CNY1.5 billion (or about US$220 million)."

"It has to do with, I think, what's fairly typical in a major merger, which is purchase price adjustments and valuations as to fair value and life, in our case, of satellites on orbit. So that work continued on into the quarter past the point where we provided our previous guidance. And the expected life of assets on orbit was increased modestly, which reduced the annual depreciation associated with those assets. — CEO Howard Lance"

"I would absolutely agree with it. I think the awareness around cardiac issues is growing, I think, for a couple of different reasons, I think where Apple is a big part of that, I think the Apple Watch has been an incredible lead generator for folks like ourselves that bring patients into see their cardiologists saying, look, I've got an alert alarm that's going off here. — iRhythm CEO Blackford at Goldman Sachs Conference, 6/10/25"

"“Yes. So on Matrox, again you mentioned it, about $100 million portfolio today. The gross margin and operating profits are accretive overall to Zebra but not quite to where some of the other public companies in the space are at. So again, we think that's, again, a great opportunity for us to grow and expand margins with -- across our machine vision portfolio over time as the business scales.” — CFO Winters, JPMorgan Conf. May 2022"

""We said we’d do $100 million in variable costs, and we are clearly going to do that. We also said we were going to attack the structural costs. We didn’t know exactly how big it was, but that we thought it was probably at least as big as the variable cost component, but it would take a couple of years to deliver that…directionally, everything is consistent with our expectations in that regard." — Fred Green, Q3 2009 Earnings Call"

""I've been around a long time, so I've seen a lot of these technologies come and go. I have been in the lab. There's a difference between the theory and the marketing, and what's actually true. What I've noticed with technologies like Berkeley Lights...is that even though the promise is there, operationally, it's really hard to integrate these emerging technologies into a conventional workflow." — Bristol Meyers Squibb employee #1"

""When you start thinking about some of the more complex antibodies that we were looking at like bispecifics and others, those became a little bit difficult to screen in terms of the sensitivity and the specificity of the system. So, that's where most of the field is moving. Single monoclonal antibodies are fine, but as soon as you start going toward the more complex structures, that becomes an issue." — Harbour Biomed ex-executive"

"in accordance with the application — Decision Notice (Section 29). "The proposed layout and design is based on informed assumptions regarding the likely specification of equipment available on the market at the time of construction." — Section 4.3 of Design and Access Statement. "Many different makes and models of solar panel arrays are available, each with differing size, mounting, and generating capacity." — Draft EN-3, 2.49.14."

""Do you expect any competition concerns out of any regions? And I think probably allude to Latin America more than the other regions. But do you expect to have to divest any assets in the case of any regulator issues?" — Owen Birrell, Analyst, Goldman Sachs. "No. Short answer is no. We've got a lot of experience navigating through all of that. We got good advice, good advisors and we don't expect any issues there." — CEO Response."

"Its Reputation in Tatters, Southwest Aims to Resume Normal Schedule on Friday — The New York Times; U.S. Senators blast Southwest holiday meltdown, labelled 'unmitigated disaster' — THOMSON REUTERS; Southwest Doubles CEO Pay, Neglects Boardroom Risks Despite Crisis — Forbes; Southwest Airlines meltdown highlights insular management team — FORTUNE; Southwest hit by record $140 million fine for holiday service meltdown in 2022 — CNN"

"“Nevro has always said you have no choice with lead placement, that everyone has to place the leads at T9/T10... So, each person has a different spinal cord. That's why you've got to do your job, you've got to do paresthesia fishing.” — KOL and high volume implanter; “I don't know how they're going to do both high frequency and paresthesia [low frequency] with Omnia. In fact, I think they're lying.” — KOL and high volume implanter"

""So we would like this material, this packaging to be inert and protect against the environmental factors like moisture and water and oxygen, and you name it, even what is called infestation and so on. But at the same time, we need to design at the moment it serve its purpose to immediately breakdown so it doesn't generate any visible waste. So it's a little bit of a paradox." — Packaging Expert at Global Consumer Products Company"

""It is but the problem we have is that without segmenting those two numbers you don't get a good feel for the actual revenue being generated. The reporting of the number is meant to give a sense of how much money goes through their systems, but you can not drive value directly from that without understanding what the split is between the technology provisioning and the actual first full service acquiring." — Former Nuvei Employee"

""The idea emerged that we should operate a base of ten or so stores as a company. This would give us a firm base of income in the event the McDonald brothers claimed default on our contract..." — Ray Kroc / Founder; "Some of our operators had tremendous wealth but no money. And we were using McDonald's stock that was trading at 25 times earnings to buy restaurants for seven times earnings" — Fred Turner / Former President and CEO"

"“Nelson Peltz and I worked closely together on the Legg Mason board. As a board member, Nelson was focused on improving operating results and strategy. There is no doubt that Nelson was an important contributor to Legg Mason’s turnaround.” — John T. Cahill, Chairman and CEO, Kraft Foods Group, Lead Independent Director of American Airlines Group, Inc., Director of Colgate-Palmolive Company, and former Director of Legg Mason, Inc."

"[At ConocoPhillips] we were always telling the Street that being an integrated company had significant value. I was an advocate late in my career that we should look seriously at splitting the company. The market was telling us that the company valuation was such that these are really two different companies. You end up with a sub-allocation of capital. I think history has shown that it was the right decision. — Sigmund Cornelius"

"So pricing has essentially been flat for us. It's still a tough pricing environment. Although with leading -- many leading brands with a 50% share, we tend to be well positioned to put them in place if needed. So pricing, again, has tended to be pretty flat. In terms of market share versus private label, we continue to gain share and win, in general, as we have for a very long period of time. — Ron Lombardi, Q2 2020 Earnings Call"